Evidence map›Paper›PMID 21397013›Full record

ReviewCellular signalling2011

Hedgehog signaling in skin cancers.

Chengxin Li, Sumin Chi, Jingwu Xie

Abstract readReview
In one paragraph

Review in Cellular signalling, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Biology · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Non-Melanoma Skin Cancers: Biological and Clinical Features.International journal of molecular sciences · 2020
    Review
  14. Article
  15. Article
  16. Article
  17. The Role of p16International journal of molecular sciences · 2017
    Review
  18. Article
  19. Review
  20. Nevoid Basal Cell Carcinoma Syndrome: A Long-Term Study in a Family.Craniomaxillofacial trauma & reconstruction · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Chengxin LiDepartment of Dermatology, Xijing hospital, Fourth Military Medical University, Xi'an 710032, China. dr.lichengxin@gmail.com
Sumin Chi
Jingwu Xie
Air Force Medical University · CNIndiana University – Purdue University Indianapolis · US

Funding

Molecular Basis of Hedgehog Signaling in CarcinogenesisR01CA094160 · NCI · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI XIE, JINGWU · 2002 to 2011
$2.8M
NCI NIH HHS CA94160NCI NIH HHS R01 CA094160
6 · The paper itself

Abstract

An increasing progress on the role of Hedgehog (Hh) signaling for carcinogenesis has been achieved since the link of Hh pathway to human cancer was firstly established. In particular, the critical role of Hh signaling in the development of Basal cell carcinoma (BCC) has been convincingly demonstrated by genetic mutation analyses, mouse models of BCCs, and successful clinical trials of BCCs using Hh signaling inhibitors. In addition, the Hh pathway activity is also reported to be involved in the pathogenesis of Squamous Cell Carcinoma (SCC), melanoma and Merkel Cell Carcinoma. These findings have significant new paradigm on Hh signaling transduction, its mechanisms in skin cancer and even therapeutic approaches for BCC. In this review, we will summarize the major advances in the understanding of Hh signaling transduction, the roles of Hh signaling in skin cancer development, and the current implications of "mechanism-based" therapeutic strategies.

Indexed as

Signal TransductionAnimalsBasal Cell CarcinomaBiological ProductsCarcinoma, Squamous CellHedgehog ProteinsHumansMiceSkin NeoplasmsBiological ProductsHedgehog Proteins

Identifiers

PMID21397013
PMCPMC3122959
OpenAlexW2061047690

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.